{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:12Z","timestamp":1791404472021,"version":"4.3.3"},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81773911"],"award-info":[{"award-number":["81773911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81690263"],"award-info":[{"award-number":["81690263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81673372"],"award-info":[{"award-number":["81673372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81361140344"],"award-info":[{"award-number":["81361140344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Basin Research Program of China","award":["2013CB 932500"],"award-info":[{"award-number":["2013CB 932500"]}]},{"name":"Development Project of Shanghai Peak Disciplines\u2013Integrated Medicine","award":["20150407"],"award-info":[{"award-number":["20150407"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.apsb.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T15:22:01Z","timestamp":1514042521000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":401,"title":["Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment"],"prefix":"10.1016","volume":"8","author":[{"given":"Ruixiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2017.11.009_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2017.11.009_bib2","first-page":"48","article-title":"Annual report on status of cancer in China, 2010","volume":"26","author":"Chen","year":"2014","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40880-015-0001-2","article-title":"Annual report on status of cancer in China, 2011","volume":"27","author":"Chen","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2017.11.009_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2017.11.009_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2017.11.009_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2017.11.009_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib9","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG)\u2014what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7150\/thno.3463","article-title":"Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy","volume":"2","author":"Yu","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2017.11.009_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2460\/ajvr.1981.42.04.667","article-title":"Preparation of resealed carrier erythrocytes and in vivo survival in dogs","volume":"42","author":"DeLoach","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/bm010164n","article-title":"Permeation of macromolecules into polyelectrolyte microcapsules","volume":"3","author":"Georgieva","year":"2002","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2017.11.009_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10717544.2016.1230903","article-title":"A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles","volume":"24","author":"Pang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2017.11.009_bib15","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1021\/nn101277w","article-title":"Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells","volume":"4","author":"Jiang","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2017.11.009_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2017.11.009_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/1061186X.2015.1052074","article-title":"Coating nanoparticles with cell membranes for targeted drug delivery","volume":"23","author":"Gao","year":"2015","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2017.11.009_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.apsb.2017.11.009_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.02.041","article-title":"Cell membrane-derived nanomaterials for biomedical applications","volume":"128","author":"Fang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2017.11.009_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2017.11.009_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.cdd.4402237","article-title":"Tumour-released exosomes and their implications in cancer immunity","volume":"15","author":"Iero","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2017.11.009_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","article-title":"Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review","volume":"32","author":"Azmi","year":"2013","journal-title":"Cancer Metast Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/iub.106","article-title":"Erythrocyte programmed cell death","volume":"60","author":"F\u00f6eller","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.apsb.2017.11.009_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14712598.2012.631909","article-title":"International seminar on the red blood cells as vehicles for drugs","volume":"12","author":"Godfrin","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.apsb.2017.11.009_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierig\u00e8","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib27","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2017.11.009_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.1068883","article-title":"Decoding the patterns of self and nonself by the innate immune system","volume":"296","author":"Medzhitov","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.apsb.2017.11.009_bib29","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.apsb.2017.11.009_bib30","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2017.11.009_bib31","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1039\/c3nr00015j","article-title":"'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach","volume":"5","author":"Hu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2017.11.009_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7150\/thno.14471","article-title":"Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors","volume":"6","author":"Luk","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2017.11.009_bib34","first-page":"543","article-title":"Using ligands to target cancer cells","volume":"10","author":"Farokhzad","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.apsb.2017.11.009_bib35","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1039\/c3nr03064d","article-title":"Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles","volume":"5","author":"Fang","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2017.11.009_bib36","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1039\/C4NR07027E","article-title":"Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane","volume":"7","author":"Fu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2017.11.009_bib37","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1002\/adfm.201603381","article-title":"Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer","volume":"26","author":"Su","year":"2016","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2017.11.009_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2017.11.009_bib40","doi-asserted-by":"crossref","first-page":"37081","DOI":"10.18632\/oncotarget.9464","article-title":"J. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma","volume":"7","author":"Pang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2017.11.009_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2017.11.009_bib42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.apsb.2017.11.009_bib43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/adhm.201500129","article-title":"Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy","volume":"4","author":"Xuan","year":"2015","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2017.11.009_bib45","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-14-3095","article-title":"Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jbm.a.35927","article-title":"Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles","volume":"105","author":"Rao","year":"2017","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.apsb.2017.11.009_bib47","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1021\/acsami.6b00853","article-title":"Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy","volume":"8","author":"Xuan","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2017.11.009_bib48","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood.V100.12.3853","article-title":"Leukocyte extravasation: chemokine transport and presentation by the endothelium","volume":"100","author":"Middleton","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2017.11.009_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/kei207","article-title":"Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways","volume":"45","author":"Garrood","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.apsb.2017.11.009_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2017.11.009_bib51","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2017.11.009_bib52","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/acsami.5b10885","article-title":"How leucocyte cell membrane modified janus microcapsules are phagocytosed by cancer cells","volume":"8","author":"He","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2017.11.009_bib53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10555-015-9594-9","article-title":"Neutrophils: important contributors to tumor progression and metastasis","volume":"34","author":"Swierczak","year":"2015","journal-title":"Cancer Metastas- Rev"},{"key":"10.1016\/j.apsb.2017.11.009_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2017.11.009_bib55","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2017.11.009_bib56","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1039\/C5NR07588B","article-title":"Monocyte cell membrane-derived nanoghosts for targeted cancer therapy","volume":"8","author":"Krishnamurthy","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2017.11.009_bib57","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/IJN.S126016","article-title":"Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer","volume":"12","author":"Zhang","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2017.11.009_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2172-12-39","article-title":"Differential MHC class I expression in distinct leukocyte subsets","volume":"12","author":"Greene","year":"2011","journal-title":"BMC Immunol"},{"key":"10.1016\/j.apsb.2017.11.009_bib59","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.apsb.2017.11.009_bib60","first-page":"3805","article-title":"Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium","volume":"63","author":"Glinsky","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2017.11.009_bib61","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1074\/jbc.M209590200","article-title":"MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by thomsen-friedenreich antigen-galectin-3 interactions","volume":"278","author":"Khaldoyanidi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2017.11.009_bib62","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","article-title":"Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy","volume":"10","author":"Chen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2017.11.009_bib63","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1002\/adma.201506086","article-title":"Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging","volume":"28","author":"Rao","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib64","doi-asserted-by":"crossref","first-page":"1604300","DOI":"10.1002\/adfm.201604300","article-title":"Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer","volume":"27","author":"Sun","year":"2017","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib65","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djs033","article-title":"Therapeutic cancer vaccines: current status and moving forward","volume":"104","author":"Schlom","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2017.11.009_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ncponc0101","article-title":"Cancer immunotherapy comes of age","volume":"2","author":"Rosenberg","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.apsb.2017.11.009_bib67","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2017.11.009_bib68","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","article-title":"The biogenesis of platelets from megakaryocyte propatelets","volume":"115","author":"Patel","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2017.11.009_bib69","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V95.8.2514","article-title":"Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers","volume":"95","author":"Harker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2017.11.009_bib70","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.ATV.0000095974.95122.EC","article-title":"Platelets in inflammation and thrombosis","volume":"23","author":"Wagner","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2017.11.009_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2017.11.009_bib72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(02)00789-1","article-title":"Platelets and cancer","volume":"3","author":"Nash","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2017.11.009_bib73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(07)61198-2","article-title":"Platelet transfusions","volume":"370","author":"Stroncek","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2017.11.009_bib74","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V85.3.824.bloodjournal853824","article-title":"Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study","volume":"85","author":"Sintnicolaas","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2017.11.009_bib75","first-page":"77","article-title":"Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components","volume":"9","author":"Eernisse","year":"1981","journal-title":"Exp Hematol"},{"key":"10.1016\/j.apsb.2017.11.009_bib76","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib77","doi-asserted-by":"crossref","first-page":"1604774","DOI":"10.1002\/adfm.201604774","article-title":"Antitumor platelet-mimicking magnetic nanoparticles","volume":"27","author":"Rao","year":"2017","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib78","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2017.11.009_bib79","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/nl504798g","article-title":"Modulating antibacterial immunity via bacterial membrane-coated nanoparticles","volume":"15","author":"Gao","year":"2015","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2017.11.009_bib80","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1002\/smll.201600624","article-title":"Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery","volume":"12","author":"Gao","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.apsb.2017.11.009_bib81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2017.11.009_bib82","doi-asserted-by":"crossref","first-page":"1701644","DOI":"10.1002\/adma.201701644","article-title":"In situ capture of bacterial toxins for antivirulence vaccination","volume":"29","author":"Wei","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2017.11.009_bib83","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/adfm.201505231","article-title":"Nanoparticle-based antivirulence vaccine for the management of methicillin-resistant Staphylococcus aureus skin infection","volume":"26","author":"Wang","year":"2016","journal-title":"Adv Funct Mater"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383517303283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383517303283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:37:12Z","timestamp":1761928632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383517303283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2211383517303283"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2017.11.009","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}